Using multi‐omics sequencing alongside various tumor‐bearing mouse models, we found that nanovaccines promote the M1 polarization of macrophages via the Gbp2‐Pin1‐NF‐κB signaling cascade, thereby achieving antitumor effects. Here, GBP2 is linked to neoplasm.